Wells Fargo’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.54K Sell
1,586
-8,395
-84% -$13.4K ﹤0.01% 5725
2025
Q1
$12.2K Buy
9,981
+659
+7% +$804 ﹤0.01% 5387
2024
Q4
$17.6K Buy
9,322
+3,752
+67% +$7.09K ﹤0.01% 5301
2024
Q3
$29.7K Buy
5,570
+2,674
+92% +$14.3K ﹤0.01% 5123
2024
Q2
$21.4K Buy
2,896
+551
+23% +$4.07K ﹤0.01% 5194
2024
Q1
$28K Buy
2,345
+319
+16% +$3.81K ﹤0.01% 5089
2023
Q4
$16K Buy
2,026
+484
+31% +$3.82K ﹤0.01% 5280
2023
Q3
$6.82K Sell
1,542
-8,620
-85% -$38.1K ﹤0.01% 5523
2023
Q2
$354K Buy
10,162
+1,742
+21% +$60.6K ﹤0.01% 3986
2023
Q1
$184K Buy
8,420
+1,483
+21% +$32.3K ﹤0.01% 4215
2022
Q4
$150K Sell
6,937
-104
-1% -$2.25K ﹤0.01% 4052
2022
Q3
$172K Buy
7,041
+639
+10% +$15.6K ﹤0.01% 4049
2022
Q2
$130K Buy
6,402
+1,556
+32% +$31.6K ﹤0.01% 4239
2022
Q1
$173K Buy
4,846
+938
+24% +$33.5K ﹤0.01% 4754
2021
Q4
$107K Buy
3,908
+3,556
+1,010% +$97.4K ﹤0.01% 5192
2021
Q3
$15K Buy
352
+350
+17,500% +$14.9K ﹤0.01% 5745
2021
Q2
$0 Sell
2
-29
-94% ﹤0.01% 6884
2021
Q1
$1K Buy
31
+11
+55% +$355 ﹤0.01% 6376
2020
Q4
$0 Buy
20
+3
+18% ﹤0.01% 6477
2020
Q3
$0 Buy
17
+6
+55% ﹤0.01% 6318
2020
Q2
$0 Buy
11
+4
+57% ﹤0.01% 6238
2020
Q1
$0 Buy
+7
New ﹤0.01% 6203
2017
Q4
Sell
-1
Closed 5940
2017
Q3
$0 Sell
1
-62
-98% ﹤0.01% 5950
2017
Q2
$10K Buy
63
+62
+6,200% +$9.84K ﹤0.01% 5432
2017
Q1
$0 Hold
1
﹤0.01% 5916
2016
Q4
$0 Hold
1
﹤0.01% 5925
2016
Q3
$0 Hold
1
﹤0.01% 5914
2016
Q2
$0 Buy
+1
New ﹤0.01% 5896